期刊文献+

肿瘤治疗新靶点TRAP1研究进展 被引量:10

Research progress of a new oncotherapy target TRAP1
下载PDF
导出
摘要 肿瘤坏死因子受体相关蛋白1(tumor necrosis factor receptor-associated protein 1,TRAP1)是热休克蛋白90(Hsp90)家族的主要成员之一,其不仅能够抵御氧化应激所诱导的凋亡,同时在维持线粒体完整性及细胞内稳态方面也发挥着重要作用。研究发现,TRAP1的异常表达与多种肿瘤的发生、发展密切相关。进一步研究表明,TRAP1是肿瘤细胞内能量代谢重新编排的关键调控因素,干预其功能可导致肿瘤细胞的死亡,但却对正常细胞没有影响。这使得TRAP1作为治疗靶点,备受人们关注。该文对TRAP1蛋白的异常表达与肿瘤研究进展进行综述,探讨TRAP1蛋白调控肿瘤进程的相关分子机制,为临床的后续研究和治疗提供参考。 Tumor necrosis factor receptor-associated protein 1( TRAP1),as one of the main members of the heat shock protein90 family,resists oxidative stress-induced apoptosis as well as predominantly maintains the integrity of mitochondria and cellular homeostasis. Abnormal expression of TRAP1 was herein closely related to the onset and progression of a wide variety of tumors. As a key regulatory factor mediating energy metabolism within tumor cells,TRAP1 may be able to kill them by interfering with such metabolism. More importantly,the abnormal expression of TRAP1 played a less important role in normal cells,allowing TRAP1 to be a particularly attractive target as it can be used in tumor treatment or interference. The relationship between abnormal expression of TRAP1 protein and tumor onset was reviewed. Besides, the mechanism by which disordered TRAP1 protein expression induced tumor formation was postulated,which may provide references for future research and clinical treatment.
出处 《中国药理学通报》 CAS CSCD 北大核心 2016年第4期459-463,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金项目资助(No81173174 81573859) 江苏省自然科学基金(NoBK2012854) 江苏省研究生创新基金(NoCXLX12_0587 KYZZ_0270) 江苏省科技厅项目(NoBY2015008-02) 江苏高校优秀科技创新团队计划 江苏高校品牌专业建设工程资助项目(NoPPZY2015A070) 江苏高校中药学优势学科建设工程资助项目(PAPD)
关键词 TRAP1 AMPK 肿瘤 异常表达 分子机制 临床治疗 TRAP1 AMPK tumor abnormal expression mo lecular mechanisms clinical treatment
  • 相关文献

参考文献4

二级参考文献56

  • 1Fidler IJ. Orthotopic implantation of human colon carcino- mas into nude mice provides a valuable model for the biol- ogy and therapy of metastasis. Cancer Metastasis Rev 1991; 10: 229-243.
  • 2Strimpakos AS, Cunningham D, Mikropoulos C, Petkar I, Barbachano Y, Chau I. The impact of carcinoembryonic anti- gen flare in patients with advanced colorectal cancer receiv- ing first-line chemotherapy. Ann Oncol 2010; 21:1013-1019.
  • 3O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96:1420-1425.
  • 4Royston D, Jackson DG. Mechanisms of lymphatic metasta- sis in human colorectal adenocarcinoma. J Pathol 2009; 217: 608-619.
  • 5Sundar SS, Ganesan TS. Role of lymphangiogenesis in can- cer. J Clin Onco12007; 25:4298-4307.
  • 6Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Pop- ulation-based analyses of lymph node metastases in colorec- tal cancer. Clin Gastroenterol Hepato12006; 4:1522-1527.
  • 7Fang W, Fan B, Xiong B. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer. Hepatogastro- enterology 2009; 56:663-666.
  • 8Carolyn C. Cancer staging handbook seventh edition. Avail- able from: URL: http://www.cancerstaging.org/staging/ index.html.
  • 9Romanucci M, MarineUi A, Sarli G, Della Salda L. Heat shock protein expression in canine malignant mammary tumours. BMC Cancer 2006; 6:171.
  • 10Kamal A, Thao L, Sensintaffar J, Zhang L, Boehrn MF, Fritz LC, Burrows FJ. A high-affinity conformation of Hsp90 con- fers tumour selectivity on Hsp90 inhibitors. Nature 2003; 425: 407-410.

共引文献33

同被引文献51

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部